Skip to main content
Clinical Trials/NCT05581927
NCT05581927WithdrawnNot Applicable

Modified Whole-Body Hypothermia for Neonates With Hypoxic-Ischemic Encephalopathy

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University1 site in 1 countryStarted: October 1, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Sponsor
Locations
1
Primary Endpoint
death

Study Overview

Brief Summary

Among term infants, hypoxic-ischemic encephalopathy due to acute perinatal asphyxia remains an important cause of brain injury in childhood. Infants with moderate encephalopathy have a 10 percent risk of death, and those who survive have a 30 percent risk of disabilities. Sixty percent of infants with severe encephalopathy die, and many, if not all, survivors are disabled. Whole-body hypothermia reduces the risk of death or disability in infants with moderate or severe hypoxic-ischemic encephalopathy.

Detailed Description

Reductions in brain temperature by 2°C to 5°C provide neuroprotection in newborn and adult animal models of brain ischemia.Brain cooling has a favorable effect on multiple pathways contributing to brain injury, including excitatory amino acids, the cerebral energy state, cerebral blood flow and metabolism, nitric oxide production, and apoptosis. Brain cooling is effective in reducing the extent of brain injury even when it is initiated up to 5.5 hours after brain ischemia in near-term sheep fetuses.But, epidemiological data showed that, in non-developed countries and areas,Whole-body hypothermia is related to the increased mortality and brain injury. The cause is unclear.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
0 Hours to 24 Hours (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • pH of 7.0 or less or a base deficit of 16 mmol per liter or more in a sample of umbilical cord blood or any blood during the first hour after birth. If, during this interval,a pH was between 7.01 and 7.15, a base deficit was between 10 and 15.9 mmol per liter. or a blood gas was not available, additional criteria were required.
  • These included an acute perinatal event (e.g., late or variable decelerations, cord prolapse, cord rupture,uterine rupture, maternal trauma, hemorrhage, or cardiorespiratory arrest) and either a 10-minute Apgar score of 5 or less or assisted ventilation initiated at birth and continued for at least 10 minutes.
  • equal to or more than 36 weeks

Exclusion Criteria

  • congenital malformation
  • parents' refusal

Outcomes

Primary Outcomes

death

Time Frame: 30 days

neonates are dead during hospital

brain injury

Time Frame: 30 days

neonates are diagnosed with brain injury

Secondary Outcomes

  • the incidence of periventricular leukomalacia(within 30 days)
  • neurodevelopmental assessment(18-36 months)
  • the incidence of suspend of Whole-Body Hypothermia(within 3 days)
  • the incidence of discharge according to the doctor's suggestion(2-3 weeks)
  • the incidence of intraventricular hemorrhage(2-3 week)

Investigators

Sponsor
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Chen Long,MD

director

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Study Sites (1)

Loading locations...

Similar Trials